Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Jeffrey Heiser

Jeffrey Heiser

Chief Scientific Officer of Microbial & Advanced Therapeutic Platforms BA Sciences

Seminars

Wednesday 22nd July 2026

Session Reserved for BA Sciences

9:30 am

Jeff Heiser

View all Speakers

View Event Brochure